汇丰为境外投资者首次通过RQFII认购内地私募基金提供托管服务
《上证报》报道,汇丰中国今日(17日)宣布,已成功协助一家境外机构投资者通过人民币合格境外机构投资者(RQFII)渠道,完成认购其集团境内外商独资私募证券投资基金管理人(WFOE PFM)推出的首只债券私募基金,为市场上首单境外投资者通过合格境外机构投资者(QFII)、RQFII渠道认购WFOE PFM的私募基金产品。
在此交易中,汇丰中国作为RQFII霸菱资产管理的托管行,协助其完成了对其集团境内WFOE PFM发行的私募证券投资基金的首笔认购。该基金为霸菱投资管理(上海)发行的首只债券私募基金。汇丰中国提供了包括投资范围更新备案、交易资金支付、资产保管以及监管报送等在内的托管服务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.